id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-346268-6oufmmw6	Infante, Maria‐Stefania	COVID‐19 in patients with hematological malignancies: A retrospective case series	2020-08-04		.txt	text/plain	666	57	51	These patients had been advised to go to the day hospital to receive blood products or due to a new hematological diagnosis or uncontrolled disease requiring therapy. We observed that the severity of pneumonia was associated with increased risk of dying from COVID-19 in hemaWe did not observe significant differences among laboratory findings and outcome either (Table 3) . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies COVID-19 outcomes in patients with hematologic disease Case fatality rate of cancer patients with COVID-19 in a New York Hospital System Clinical outcome of coronavirus disease 2019 in haemato-oncology patients Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience COVID-19 and the clinical hematology laboratory	./cache/cord-346268-6oufmmw6.txt	./txt/cord-346268-6oufmmw6.txt